QGEN
Qiagen N.V.
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$43.57
−0.67%Forward multiples
Based on analyst estimates
- P/E forward
- 17.46x
- P/E 2026E
- 17.94x
- P/E 2027E
- 16.69x
- P/E 2028E
- 15.23x
- P/S forward
- 4.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.34x
- PEG TTM
- 0.80x
- Price / book
- 2.68x
- Price / sales
- 4.28x
- Price / cash flow
- 13.75x
Enterprise value
- Enterprise value
- $9.8B
- EV / sales
- 4.69x
- EV / EBITDA
- 13.37x
- EV / EBIT
- 18.50x
- Market cap
- $9.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026